Daniel O'Day's Securities Transactions in Gilead Sciences, Inc.

Daniel O'Day, an officer and director of Gilead Sciences, Inc., has filed a Form 144 notice indicating his intention to sell securities. The filing details the sale of 10,000 common shares on October 28, 2025, with an aggregate market value of $1,193,926. Additionally, O'Day has sold 10,000 common shares on September 29, 2025, for $1,116,564, and another 10,000 common shares on August 28, 2025, for $1,136,300. The securities to be sold were acquired as restricted stock on March 10, 2022, and March 1, 2020. The transactions are being handled by Morgan Stanley Smith Barney LLC Executive Financial Services.